摘要
目的观察老年期与非老年期焦虑症的临床表现,研究影响焦虑症的相关因素.方法:将81 例焦虑症患者分成老年期组和非老年期组,其中首发年龄≥60 岁的40 例患者为老年期,首发年龄〈60 岁的41 例患者为非老年组.针对两组患者的临床资料进行比较和分析,并对两组患者定期采用HAMA 量表评定,比较两组患者患者的临床治疗效果.结果:在身体疾病方面,老年组明显高于非老年组,从HAMA 总分上看,老年组明显高于非老年组,通过2 个月的治疗老年组的总有效率低于非老年组的总有效率,组间比较差异显著(P〈0.05).结论:在焦虑症的临床特征方面,老年期和非老年期表现出明显的不同,非老年期焦虑症的治疗效果明显高于老年期焦虑症的治疗效果.
Objective: To observe the clinical manifestation of senile and non senile anxiety, factors related with anxiety. Methods: the diagnosis of 81 cases of patients were treated with CCMD-3, and in accordance with the diagnostic criteria for anxiety disorders. 81 patients with anxiety disorder patients were divided into old age group and non old age group, including 40 cases of the first 60 years of age or older patients with old age, 41 patients with first-episode age < 60 years old patients and non elderly group. Comparison and analysis of theclinical data of the two groups, and two groups of patients regularly using HAMA scale assessment, clinical treatment effects were compared between the two groups of patients. Results: in the body disease, the elderly group was significantly higher than that in the non elderly group, from the HAMAtotal score, the elderly group was significantly higher than that in the non elderly group, the treatment of senile group 2 months the total efficiency ofthe total efficiency is lower than the non elderly group, the difference between groups was significant(P < 0.05). Conclusion: in the clinical features of anxiety, senile and non senile showed significantly different,anxiety, non aged treatment effect was significantly higher than that of elderly anxiety disorder treatment.
出处
《世界中医药》
CAS
2015年第A01期411-412,共2页
World Chinese Medicine